XTANDI is FDA-approved to treat two types of advanced prostate cancer
XTANDI may help men with
advanced prostate cancer
that
HAS SPREAD
e
r
ua
u
r
D
q
s
gs
For men with prostate cancer that
no longer responds to treatment
that lowers testosterone and has
spread to other parts of the body.
This is also known as metastatic
castration-resistant prostate
cancer (mCRPC).
m
o
.c
XTANDI may help men with
advanced prostate cancer
that
HAS NOT SPREAD
For men with prostate cancer that
no longer responds to treatment
that lowers testosterone and has
not spread to other parts of the
body. This is also known as
non-metastatic castration-resistant
prostate cancer (nmCRPC).